Fundraising FoxFlame Biosciences
New York, US · Founded 2017 · Delaware corporation · 1 known investors
Find your way into Flame Biosciences
Sign up to see every warm intro you have to Flame Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Flame Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
PD
Pamela DemainVice President, Business Development
GA
George AvgerinoVice President, Manufacturing
LG
Leonid GorelikHead of Translational Medicine and Research
HW
Harlan WeismanPresident and Chief Executive Officer
RS
Robert SteinNamed on SEC filing
OT
Opler TimNamed on SEC filing
DB
David BarrettNamed on SEC filing
Investors · 1
Rock Springs CapitalreportedBaltimore
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$108.5M disclosed across 2 rounds · 2020
▶$100MraisedSep 2020 · 40 investors · BiotechnologyRule 506(b)
▶$100MraisedSep 2020 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert SteinDirector
- David BarrettExecutive Officer, Director
- Tim OplerDirector
- George AvgerinosExecutive Officer
- Harlan WeismanExecutive Officer, Director
- Offering amount
- $100M
- Amount sold
- $100M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$8.5MraisedMar 2020 · 58 investors · BiotechnologyRule 506(b)
▶$8.5MraisedMar 2020 · 58 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Pamela DemainExecutive Officer
- George AvgerinoExecutive Officer
- Leonid GorelikExecutive Officer
- Robert SteinDirector
- Opler TimDirector
- David BarrettExecutive Officer, Director
- Harlan WeismanExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $8.5M
- Minimum investment
- $25K
- Sales commissions
- $712.5K
- Placement agents
- Jonathan C. Rich
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Flame Biosciences's investors?
- Flame Biosciences's investors include Rock Springs Capital.
- How much funding has Flame Biosciences raised?
- Flame Biosciences has disclosed $108.5M raised across 2 rounds.
- Where is Flame Biosciences headquartered?
- Flame Biosciences is headquartered in New York, US.